Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation
European Cardiology Review · 10.07.2026
DOI: 10.15420/ecr.2026.31 ↗Kurz gefasst
Editorial in der Zeitschrift European Cardiology Review, online erschienen am 10.07.2026. Verfasst von Mohammed I Danjuma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation Doha, Qatar. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation Doha, Qatar.
- Internal Medicine Residency Programme, Hamad Medical Corporation Doha, Qatar.
- Acute Medicine Unit, NHS Grampian (Dr Gray's Hospital) Elgin, Scotland.
- General Medicine Department, Weill Cornell College of Medicine New York, NY, US/Doha, Qatar.
- Department of Inpatient Pharmacy, Division of Clinical Pharmacy, Hamad Medical Corporation Doha, Qatar.
ORCID-Profile: Mohammed I Danjuma, Ranim Bassut, Layaly Bakir, Mohamed Nabil Elshafei
Zitieren
APA
Danjuma, M. I., Bassut, R., Bakir, L., & Elshafei, M. N. (2026). Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation. European Cardiology Review. https://doi.org/10.15420/ecr.2026.31
Vancouver
Danjuma MI, Bassut R, Bakir L, Elshafei MN. Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation. European Cardiology Review. 2026. doi:10.15420/ecr.2026.31
BibTeX
@article{Danjuma2026,
author = {Danjuma, Mohammed I and Bassut, Ranim and Bakir, Layaly and Elshafei, Mohamed Nabil},
title = {Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation},
journal = {European Cardiology Review},
year = {2026},
doi = {10.15420/ecr.2026.31}
}
EUVIMED